ESR1 and breast cancer: Previous studies suggest that human breast cancer cells become dependent on NOTCH1 in the absence of ERα or ERB2 signaling [15,18,20], raising the possibility that NOTCH inhibition may have therapeutic potential in TN human basal-like breast cancers.